All In MedTech

Device Trial Radar · NCT05149755

Evolut™ EXPAND TAVR II Pivotal Trial

Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingTitle says "pivotal". Randomized with 650 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

650

Planned (sponsor's estimate)

Start

Apr 27, 2022

Primary completion

Sep 2027

Study completion Dec 2034

Sponsor

Lead sponsor
Medtronic CardiovascularPublic (MDT)
Sponsor type
Industry
First posted
Dec 8, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Conditions

  • Moderate Aortic Valve Stenosis

Interventions

  • Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)Device

    Patients will have a Transcatheter Aortic Valve Replacement (TAVR) with either an Evolut PRO+ TAVR, or Evolut FX TAVR, heart valve, and given clinical site-determined guideline-directed management and therapy (GDMT).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite rate of all-cause mortality, all-stroke, life threatening or fatal bleeding, acute kidney injury, hospitalization due to device or procedure-related complication, or valve dysfunction requiring reintervention.Time frame: 30 days
  2. Composite rate of all-cause mortality, heart failure hospitalization or event, or medical instability leading to aortic valve replacement or re-intervention.Time frame: 2 years

Locations

94 sites in 16 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham (UAB) Hospital

    Birmingham, Alabama

  • Abrazo Arizone Heart Hospital

    Phoenix, Arizona

  • HonorHealth Scottsdale Shea Medical Center

    Scottsdale, Arizona

91 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.